Scor Se (OTCMKTS:SCRYY – Get Free Report) was the recipient of a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 90,700 shares, an increase of 22,575.0% from the October 31st total of 400 shares. Based on an average daily trading volume, of 95,700 shares, the short-interest ratio is currently 0.9 days.
Scor Stock Up 1.2 %
Shares of OTCMKTS SCRYY opened at $2.49 on Thursday. The firm has a market capitalization of $4.47 billion, a P/E ratio of -61.50 and a beta of 1.30. The stock’s 50-day simple moving average is $2.25 and its two-hundred day simple moving average is $2.40. Scor has a twelve month low of $1.82 and a twelve month high of $3.53.
Wall Street Analysts Forecast Growth
SCRYY has been the subject of a number of analyst reports. Berenberg Bank upgraded shares of Scor to a “strong-buy” rating in a research report on Friday, October 4th. Keefe, Bruyette & Woods upgraded shares of Scor from a “hold” rating to a “moderate buy” rating in a research report on Tuesday, November 19th.
Scor Company Profile
SCOR SE, together with its subsidiaries, provides life and non-life reinsurance products in Europe, the Middle East, Africa, the Americas, Latin America, and Asia Pacific. It operates in two segments, SCOR P&C and SCOR L&H. The SCOR P&C segment offers reinsurance products in the areas of property, motors, casualty treaties, credit and surety, decennial insurance, aviation, marine and energy, engineering, agricultural risks, and property catastrophes; specialties insurance products, including business solutions, political and credit risks, cyber, and environmental liability; and business ventures and partnerships.
Recommended Stories
- Five stocks we like better than Scor
- 10 Best Airline Stocks to Buy
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Want to Profit on the Downtrend? Downtrends, Explained.
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Scor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scor and related companies with MarketBeat.com's FREE daily email newsletter.